Cited by 357Autophagy in Disease and TherapyRetinal Diseases and TreatmentsRetinal Development and Disorders

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration

Open access

Abstract

Age-related macular degeneration (AMD) is a devastating neurodegenerative disease and a major cause of blindness in the developed world. Owing to its complexity and the lack of an adequate human model that recapitulates key aspects of the disease, the molecular mechanisms of AMD pathogenesis remain poorly understood. Here we show that cultured human retinal pigment epithelium (RPE) from AMD donors (AMD RPE) are functionally impaired and exhibit distinct phenotypes compared with RPE cultured from normal donors (normal RPE). Accumulation of lipid droplets and glycogen granules, disintegration of mitochondria, and an increase in autophagosomes were observed in AMD RPE cultures. Compared with normal RPE, AMD RPE exhibit increased susceptibility to oxidative stress, produce higher levels of reactive oxygen species (ROS) under stress conditions, and showed reduced mitochondrial activity. Measurement of the ratio of LC3-II/ LC3-I, revealed impaired autophagy in AMD RPE as compared with normal RPE. Autophagic flux was also reduced in AMD RPE as compared with normal RPE, as shown by inability of AMD RPE to downregulate p62 levels during starvation. Impaired autophagic pathways were further shown by analyzing late autophagic vesicles; immunostaining with lysosome-associated membrane protein 1 (LAMP-1) antibody revealed enlarged and annular LAMP-1-positive organelles in AMD RPE as opposed to smaller discrete puncta observed in normal RPE. Our study provides insights into AMD cellular and molecular mechanisms, proposes dysfunctional autophagy as an underlying mechanism contributing to the pathophysiology of the disease, and opens up new avenues for development of novel treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cddis.2016.453

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (a-f) Isolation and characterization of RPE from donors. The isolated RPE from AMD and control donors express RPE-specific proteins ZO-1, Bestrophin and CRALBP. A representative image of immunostaining is shown for each group. Bar represents 100 μM. (g) Gene expression analysis by qRT-PCR confirming the expression of RPE marker genes in the RPE isolated from donors (controls 6, 10, 23 and 25; AMD 9, 17, 19 and 32). (h) Gene expression analysis of AMD-associated genes in AMD and normal RPE. **P<0.01, ****P<0.0001
Figure 1 (a-f) Isolation and characterization of RPE from donors. The isolated RPE from AMD and control donors express RPE-specific proteins ZO-1, Bestrophin and CRALBP. A representative image of immunostaining is shown for each group. Bar represents 100 μM. (g) Gene expression analysis by qRT-PCR confirming the expression of RPE marker genes in the RPE isolated from donors (controls 6, 10, 23 and 25; AMD 9, 17, 19 and 32). (h) Gene expression analysis of AMD-associated genes in AMD and normal RPE. **P<0.01, ****P<0.0001CC BY · PubMed Central
Figure 2 AMD RPE exhibit disease phenotypes. (a-d) EM images of normal 10 (a and c) and AMD 9 (b and d) RPE showing disease phenotypes. Red arrows indicate the observed morphological differences. Higher magnification insets show the observed phenotypes (in b and d), in comparison with the normal cellular structures (in c). L, lysosomes; M, mitochondria; RER, rough ER; LD, lipid droplets; F, cytoskeletal fascicles. (e and f) Number of APs and damaged mitochondria were counted (n=3) in four random regions per cell. The images used for counting were all the same size and same magnification. The mean±S.D. and the P-values were calculated for statistical significance. P-value equals 0.0002 (***) and 0.0001 (****) for (e and f), respectively
Figure 2 AMD RPE exhibit disease phenotypes. (a-d) EM images of normal 10 (a and c) and AMD 9 (b and d) RPE showing disease phenotypes. Red arrows indicate the observed morphological differences. Higher magnification insets show the observed phenotypes (in b and d), in comparison with the normal cellular structures (in c). L, lysosomes; M, mitochondria; RER, rough ER; LD, lipid droplets; F, cytoskeletal fascicles. (e and f) Number of APs and damaged mitochondria were counted (n=3) in four random regions per cell. The images used for counting were all the same size and same magnification. The mean±S.D. and the P-values were calculated for statistical significance. P-value equals 0.0002 (***) and 0.0001 (****) for (e and f), respectivelyCC BY · PubMed Central
Figure 3 Lipid and glycogen accumulation in AMD RPE. (a) (Left): graph showing the quantification of lipid droplets in normal and AMD RPE, as determined by counting the lipid droplets in three random fields of stained images (shown in right panel), in the five normal and five AMD RPE (n=5). Asterisk (*) indicates statistically significant difference in number of lipid droplets between control and AMD RPE. (a) (Right): analysis of cytoplasmic lipid by fluorescence staining in control and AMD RPE, showing higher intensity of lipid staining in the AMD RPE. (b) (Left): measurement of glycogen accumulation by colorimetric assay showing statistically significant higher concentration in the AMD RPE compared with control RPE (n=5). (b) (Right): graph of the average glycogen concentrations calculated from five normal and five AMD RPE shown in the left graph. Red line indicates the threshold that separates AMD and normal RPE. Asterisk (*) indicates statistically significant differences in glycogen concentrations between the AMD and control RPE. P-values in (a and b) are determined by ANOVA followed by Tukey's test, with P<0.05
Figure 3 Lipid and glycogen accumulation in AMD RPE. (a) (Left): graph showing the quantification of lipid droplets in normal and AMD RPE, as determined by counting the lipid droplets in three random fields of stained images (shown in right panel), in the five normal and five AMD RPE (n=5). Asterisk (*) indicates statistically significant difference in number of lipid droplets between control and AMD RPE. (a) (Right): analysis of cytoplasmic lipid by fluorescence staining in control and AMD RPE, showing higher intensity of lipid staining in the AMD RPE. (b) (Left): measurement of glycogen accumulation by colorimetric assay showing statistically significant higher concentration in the AMD RPE compared with control RPE (n=5). (b) (Right): graph of the average glycogen concentrations calculated from five normal and five AMD RPE shown in the left graph. Red line indicates the threshold that separates AMD and normal RPE. Asterisk (*) indicates statistically significant differences in glycogen concentrations between the AMD and control RPE. P-values in (a and b) are determined by ANOVA followed by Tukey's test, with P<0.05CC BY · PubMed Central
Figure 4 AMD RPE are more susceptible to oxidative stress and show lower mitochondrial activity. (a and b) Cell viability assays of AMD and control RPE treated with increasing concentrations of H2O2 for 24 h (a) and 48 h (b). Higher susceptibility of the AMD RPE under oxidative stress conditions is observed in 48 h. (c) ROS production under stress is significantly higher in AMD RPE. (d and e) AMD RPE have significantly lower mitochondrial activity, as indicated by their ATP levels measured by a luminescence assay in the presence of hexokinase inhibitor. (d) ATP levels produced by mitochondria are significantly lower in AMD RPE as measured in the presence of hexokinase inhibitor. (e) ATP levels produced by glycolysis are higher in AMD RPE as measured in the absence of hexokinase inhibitor. The difference in ATP levels measured in the presence (d) and absence (e) of hexokinase inhibitor show glycolysis as the major source of ATP production in AMD RPE. Asterisks (*) indicate statistical significance, determined by the ANOVA analysis followed by Tukey's test (P-value<0.05, n=5 for each sample)
Figure 4 AMD RPE are more susceptible to oxidative stress and show lower mitochondrial activity. (a and b) Cell viability assays of AMD and control RPE treated with increasing concentrations of H2O2 for 24 h (a) and 48 h (b). Higher susceptibility of the AMD RPE under oxidative stress conditions is observed in 48 h. (c) ROS production under stress is significantly higher in AMD RPE. (d and e) AMD RPE have significantly lower mitochondrial activity, as indicated by their ATP levels measured by a luminescence assay in the presence of hexokinase inhibitor. (d) ATP levels produced by mitochondria are significantly lower in AMD RPE as measured in the presence of hexokinase inhibitor. (e) ATP levels produced by glycolysis are higher in AMD RPE as measured in the absence of hexokinase inhibitor. The difference in ATP levels measured in the presence (d) and absence (e) of hexokinase inhibitor show glycolysis as the major source of ATP production in AMD RPE. Asterisks (*) indicate statistical significance, determined by the ANOVA analysis followed by Tukey's test (P-value<0.05, n=5 for each sample)CC BY · PubMed Central
Figure 5 Autophagy is dysfunctional in AMD RPE. (a and c) Analysis of autophagy dynamics in normal RPE (a), and AMD RPE (c), n=5. LC3 immunoblots of control and AMD RPE under three different conditions, nutrient, starvation in the presence of IGF-1, and starvation in the absence of IGF-1 are shown. Beta actin is used as a normalization control. Spliced membranes are indicated by the vertical lines. (b and d) The ratios of the LC3-II/LC3-I levels as determined by densitometry are illustrated in the graphs, showing that an increase in autophagy dynamics in the absence of IGF-1 under starvation conditions is observed only in normal, but not in AMD RPE. Densitometry was performed on three repeats of the experiment for each sample in five normal and five AMD RPE (b and d). Asterisks in (b) represent P-value <0.0001 of LC3-II/LC3-I ratios as determined by one-way Anova followed by Tukey's test. (e and f) Autophagic flux is lower in AMD RPE as compared with normal RPE. (e) Immunoblot of p62, demonstrating lower autophagic flux in AMD RPE as shown by inability of AMD RPE to downregulate p62 levels during starvation in the absence of IGF-1. Beta actin is used as a normalization control. (f) Relative expression of p62 in control and AMD RPE in the presence and absence of IGF-1, as determined by densitometry analysis of the immunoblot in (e), n=5. The asterisks (*) indicate statistical significance determined by ANOVA followed by Tukey's test (P<0.05)
Figure 5 Autophagy is dysfunctional in AMD RPE. (a and c) Analysis of autophagy dynamics in normal RPE (a), and AMD RPE (c), n=5. LC3 immunoblots of control and AMD RPE under three different conditions, nutrient, starvation in the presence of IGF-1, and starvation in the absence of IGF-1 are shown. Beta actin is used as a normalization control. Spliced membranes are indicated by the vertical lines. (b and d) The ratios of the LC3-II/LC3-I levels as determined by densitometry are illustrated in the graphs, showing that an increase in autophagy dynamics in the absence of IGF-1 under starvation conditions is observed only in normal, but not in AMD RPE. Densitometry was performed on three repeats of the experiment for each sample in five normal and five AMD RPE (b and d). Asterisks in (b) represent P-value <0.0001 of LC3-II/LC3-I ratios as determined by one-way Anova followed by Tukey's test. (e and f) Autophagic flux is lower in AMD RPE as compared with normal RPE. (e) Immunoblot of p62, demonstrating lower autophagic flux in AMD RPE as shown by inability of AMD RPE to downregulate p62 levels during starvation in the absence of IGF-1. Beta actin is used as a normalization control. (f) Relative expression of p62 in control and AMD RPE in the presence and absence of IGF-1, as determined by densitometry analysis of the immunoblot in (e), n=5. The asterisks (*) indicate statistical significance determined by ANOVA followed by Tukey's test (P<0.05)CC BY · PubMed Central
Figure 6 Autophagolysosomes are swollen in AMD RPE. Swollen LAMP-1-positive organelles, commonly indicative of defective lysosomal function, are consistently observed in AMD RPE (white arrowheads, AMD 32 (a) and AMD 9 (c)), but not in healthy RPE (white arrows, Ctrl 10 (b) and Ctrl 6 (d)). Insets (1–8) are × 5 magnifications of indicated boxed regions, scale bar represents 20 μm
Figure 6 Autophagolysosomes are swollen in AMD RPE. Swollen LAMP-1-positive organelles, commonly indicative of defective lysosomal function, are consistently observed in AMD RPE (white arrowheads, AMD 32 (a) and AMD 9 (c)), but not in healthy RPE (white arrows, Ctrl 10 (b) and Ctrl 6 (d)). Insets (1–8) are × 5 magnifications of indicated boxed regions, scale bar represents 20 μmCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Cited by

Sorted by citations

Items 201–300 of 357

Metadata

Authors
Golestaneh, N., Chu, Y., Xiao, Y.-Y., Stoleru, G. L., & Theos, A. C.
Affiliations
  • Georgetown University Medical Center (US)
  • Georgetown University (US)
Corresponding author
Golestaneh, Nady
Venue
Cell Death & Disease
Published
2017-01-05
Volume
8
Issue
1
Pages
e2537-e2537
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2569601267
Cited by
357
References
83
Citations by year
2026: 35 · 2025: 31 · 2024: 41 · 2023: 31 · 2022: 51 · 2021: 52 · 2020: 61 · 2019: 25 · 2018: 23 · 2017: 7
FWCI
24.85
Type
journal article
Language
en
Open access
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • BrightFocus Foundation
  • Children's National Hospital
  • National Institutes of Health
  • National Eye Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
Keywords
age-related macular degeneration, retinal pigment epithelium, autophagy dysfunction, autophagic flux, lipid droplets, glycogen granules, mitochondrial dysfunction, oxidative stress, reactive oxygen species, LC3-II/LC3-I ratio, p62, LAMP1, lysosomes, AMD pathogenesis
MeSH terms
Autophagosomes, Cells, Cultured, Glycogen, Humans, Macular Degeneration, Mitochondria, Reactive Oxygen Species, Oxidative Stress, Lysosomal Membrane Proteins, Lysosomal-Associated Membrane Protein 1, Retinal Pigment Epithelium, Lipid Droplets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review